FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)

View source ↗

Summary

FDA supplemental approval granted for Pataday Once Daily Relief with olopatadine hydrochloride, expanding labeling for once-daily dosing in allergic conjunctivi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Perennial Allergic Conjunctivitis
• Seasonal Allergic Conjunctivitis

Drugs mentioned

• PATADAY ONCE DAILY RELIEF (OLOPATADINE HYDROCHLORIDE)

Snippet

SUPPL AP for PATADAY ONCE DAILY RELIEF (OLOPATADINE HYDROCHLORIDE)